Bhakta B, Cozens JA, Chamberlain MA,et al. The impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol neurosurg Psychiatry2000;69:217-21.

In table 2, p219 in the column relating to carer burden, BT-A, the values −0.77 (−1.8, 0) should read −0.67(−1.8, 0) and −1.0 (−2.0, 0) should read −0.5(−2.0, 0)